Back Stocks profile

Stock analysis tool for investors

Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE:532488

₹5547.05 142.70 (2.64%) 1D

Pharmaceuticals & Biotechnology

Open free demat account View detailed Technical chart

Open an Account with Bigul

Performance Online share trading app

Today’s low

5398.60

Today’s High

5566.50

52W low

3295.30

52W High

5583.00

Open Price

5401.70

Prev. Close

5404.3500

Volume

401450.00

Value

2226863222.50

Fundamentals Open free demat account

Market Cap

147256.80

Price to Earnings

88.00

Price to Book Value

10.80

Dividend Yield

0.50

PE to Growth

6.60

Op Revenue TTM

8185.00

Net Profit TTM

1674.00

Cash From Operating Activity

1261.00

Return on Equity %

11.78

EMA & SMA

Online share trading app Open free demat account

Bullish Moving Averages

16

Bearish Moving Averages

0

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

08 Oct, 2024

51.9

Week

51.6

Month

60.8

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

5504.07

PIVOT

First Resistance

5609.48

Second Resistance

5671.92

Third Resistance

5777.33

First Support

5441.63

Second Support

5336.22

Third Support

5273.78

Relative Strength Index

69.94

Money Flow Index

74.5

MACD

97.24

MACD Signal

112.51

Average True Range

135.99

Average Directional Index

37.23

Rate of Change (21)

7.97

Rate of Change (125)

47.99

Day Commodity Channel Index

141.7

William

-10.52

BETA

1 Month

0.33

3 Month

0.73

1 Year

0.53

3 Year

0.18

PRICE CHANGE ANALYSIS

1.91%

1 Week

Low

High

5241.7

5566.5

7.97%

1 Month

Low

High

5082.2

5582.95

19.81%

3 Months

Low

High

4395.3

5582.95

47.99%

6 Months

Low

High

3641

5582.95

49.04%

1 Year

Low

High

3295.3

5582.95

Bigul
30 Sep 2024

DIVI'S LABORATORIES LTD. - 532488 - Closure of Trading Window

Intimation of closure of Trading Window from October 01, 2024 till 48 hours of declaration of financial results of the Company for the quarter and half year ended September 30, 2024.
Bigul
14 Sep 2024

DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Credit Rating

Intimation of reaffirmation of credit rating.
Bigul
12 Aug 2024

DIVI'S LABORATORIES LTD. - 532488 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Please find the enclosed scrutinizers report on the AGM resolutions along with proceedings of the AGM and Voting results.
Bigul
12 Aug 2024

DIVI'S LABORATORIES LTD. - 532488 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Please find the enclosed proceedings of the 34th Annual General Meeting, voting results and report of scrutinizer on the AGM resolutions.
Bigul
08 Aug 2024

DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of earnings conference call held on August 03, 2024.
Bigul
05 Aug 2024

Q1FY25 Quarterly Result Announced for Divi's Laboratories Ltd.

Pharmaceuticals company Divi's Laboratories announced Q1FY25 results: Financial Highlights: Divi's Laboratories has earned a total income Rs 2,197 crore for Q1FY25 on a consolidated basis as against an income of Rs 1,859 crore for the corresponding quarter of last year. Profit before Tax (PBT) for the current quarter amounted to Rs 604 crore as against a PBT of Rs 492 crore for the corresponding quarter of the last year and a PBT of Rs 713 crore for the fourth quarter of last year. The Company earned a Profit after Tax (PAT) of Rs 430 crore for the current quarter as against a PAT of Rs 356 crore for the corresponding quarter of the last year. PAT for the fourth quarter of last year was Rs 538 crore. Forex loss for the current quarter amounted to Rs 1 crore as against a gain of Rs 3 crore during the corresponding quarter of the last year. Result PDF
Bigul
05 Aug 2024

DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication of extracts of unaudited financial results for the quarter ended June 30, 2024.
Bigul
05 Aug 2024

Earnings growth priced-in Divi's Labs stock, niche biz to expand: Analysts

Shares of Divis Laboratories fell 2.41 to Rs 4870 per share on the BSE in Monday's intraday deals. This came despite the company delivering a 21 percent year-on-year (YoY) rise in net profit
03 Aug 2024

Divi's Laboratories Results Earnings Call for Q1FY25

Conference Call with Divi's Laboratories Ltd. Management and Analysts on Q1FY25 Performance and Outlook. Listen to the full earnings transcript.
Bigul
03 Aug 2024

DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Audio recording of Q1 FY25 earnings conference call held on August 03, 2024.
See all News

FAQs

Investment Platform in India

The latest market price of Divi's Laboratories Ltd. on NSE was Rs. 5547.05 as of today.

The opening share price of Divi's Laboratories Ltd. was Rs. 5401.70 as of today.

The 52-week high share price of Divi's Laboratories Ltd. was Rs. 5583.00.

The 52 week low share price of Divi's Laboratories Ltd. was Rs. 3295.30.

Please find Corporate actions section for more details.

The PE ratio of Divi's Laboratories Ltd. is 6.60. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Divi's Laboratories Ltd. was on 2024-08-02 for Rs. 30 per share. According to today’s share price, the dividend yield of Divi's Laboratories Ltd. stands at 0.50. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Divi's Laboratories Ltd. was as of 2015-09-23. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Divi's Laboratories Ltd. was as of 2007-08-03. The split ratio declared in this issue was 10:2. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Divi's Laboratories Ltd..

Investment Platform in India
Close

Let's Open Free Demat Account